- Home
- VOC vs CNTX Comparison
VOC vs CNTX Comparison
Compare VOC & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- CNTX
- Stock Information
- Founded
- VOC 2010
- CNTX 2015
- Country
- VOC United States
- CNTX United States
- Employees
- VOC N/A
- CNTX 9
- Industry
- VOC Oil & Gas Production
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- CNTX Health Care
- Exchange
- VOC Nasdaq
- CNTX Nasdaq
- Market Cap
- VOC 55.3M
- CNTX 78.0M
- IPO Year
- VOC 2011
- CNTX 2021
- Fundamental
- Price
- VOC $2.84
- CNTX $0.78
- Analyst Decision
- VOC
- CNTX Strong Buy
- Analyst Count
- VOC 0
- CNTX 6
- Target Price
- VOC N/A
- CNTX $6.50
- AVG Volume (30 Days)
- VOC 80.3K
- CNTX 94.4K
- Earning Date
- VOC 01-01-0001
- CNTX 05-07-2025
- Dividend Yield
- VOC 19.97%
- CNTX N/A
- EPS Growth
- VOC N/A
- CNTX N/A
- EPS
- VOC 0.63
- CNTX N/A
- Revenue
- VOC $11,917,424.00
- CNTX N/A
- Revenue This Year
- VOC N/A
- CNTX N/A
- Revenue Next Year
- VOC N/A
- CNTX N/A
- P/E Ratio
- VOC $4.58
- CNTX N/A
- Revenue Growth
- VOC N/A
- CNTX N/A
- 52 Week Low
- VOC $2.44
- CNTX $0.55
- 52 Week High
- VOC $6.00
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- VOC 40.92
- CNTX 45.08
- Support Level
- VOC $2.81
- CNTX $0.74
- Resistance Level
- VOC $2.91
- CNTX $0.85
- Average True Range (ATR)
- VOC 0.15
- CNTX 0.09
- MACD
- VOC -0.02
- CNTX -0.02
- Stochastic Oscillator
- VOC 7.14
- CNTX 13.67
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.